In an unprecedented move toward sustainability, Balrampur Chini Mills Limited (BCML) has announced strategic agreements with three technology giants: Sulzer AG, Alpine Engineering GmbH, and Jacobs Solutions India Private Limited, marking the dawn of India’s first bioplastics plant. With a robust deal highlighting the production capabilities of 75,000 tonnes of compostable and fully recyclable bioplastic […]
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), known for its significant strides in the medical cannabis sector, has announced a business combination with Kadimastem Ltd, an Israeli clinical cell therapy company. This strategic reverse merger, detailed in a non-binding term sheet and subsequent Loan Agreement, signals a pivotal shift in IM Cannabis Corp’s business direction, […]
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare Acquisition Corp. (AHAC), a blank check company. The transaction values the combined entity at approximately $1.1 billion, positioning Humacyte as a pioneer in the development of universally implantable bioengineered human tissues at a commercial scale. Innovative Biotechnology […]
Swiss pharmaceutical giant Roche has reached a major agreement to acquire the U.S.-based gene therapy company Spark Therapeutics in an all-cash deal valued at $4.3 billion. Under the terms of the deal, Roche will purchase 100% of Spark Therapeutics for $114.50 per share. This acquisition is a strategic move to expand Roche’s capabilities in the […]
Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire Loxo Oncology, a pioneering biopharmaceutical company based in Stamford, Connecticut. The all-cash deal, valued at $8 billion, is poised to significantly enhance Lilly’s oncology portfolio by integrating Loxo Oncology’s cutting-edge precision medicines. A strategic move in oncology […]
Millendo Therapeutics has finalized its merger with OvaScience, a Massachusetts-based biotech firm specializing in female infertility treatments. The transaction, initially announced in August 2018, concludes with Millendo receiving a total of $85.4 million. This sum comprises $35.9 million in cash from OvaScience and an additional $49.5 million from a related financing effort. The merger’s completion […]
Evox Therapeutics, an innovative biotechnology company spun out from Oxford University, has successfully raised £35.5 million in a Series B financing round. The round was led by Redmile Group, with notable new investments from Google’s GV, Cowen Healthcare Investments, and several others. This funding follows a previous £10 million raised from Oxford Sciences Innovation during […]
Novo Nordisk, a leading Danish pharmaceutical company, has completed a significant acquisition of Ziylo, a biotechnology spin-out from the University of Bristol, for a deal potentially worth over $800 million. This acquisition grants Novo Nordisk full rights to Ziylo’s innovative glucose binding molecules, crucial for the development of glucose responsive insulins. Strategic Importance of the […]
Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million, a strategic move to enhance its portfolio of solid tumor treatments. The acquisition, which involves Seattle Genetics paying $10 per share in cash for the California-based company, is set to significantly advance its research in cancer therapies, […]
French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately €3.9 billion. This strategic acquisition surpasses a previous offer of €2.6 billion from Danish pharmaceutical company Novo Nordisk, which Ablynx had rejected citing undervaluation. Details of the Acquisition Ablynx, based in Ghent and established in 2001 as […]
